on-operative management of TFCC injury; a randomised, control trial investigating hand therapy, wrist splint and cortisone injection for triangular fibrocartilage complex injuries in the wrist

Not Applicable

Recruiting

• Conditions: Triangular fibrocartilage complex injury; Musculoskeletal - Other muscular and skeletal disorders; Injuries and Accidents - Other injuries and accidents; Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation

• Registration Number: ACTRN12619000886189
• Lead Sponsor: Brisbane Hand & Upper Limb Research Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-06-24
• Last Update Posted: 16 March 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

Participants will be eligible for inclusion in the study if they are:
1. Have a clinical diagnosis of TFCC localised, ulnar-sided wrist pain
2. Are between 6 weeks and 12 months from initial injury;
3. MRI confirmation of isolated TFCC tear;

Exclusion Criteria

Participants will be excluded from the study if they present with:
1.Frank instability of the distal radioulnar joint (DRUJ);
2.Arthritis of the distal radioulnar joint (DRUJ);
3.Concomitant injury (e.g. scaphoid fracture) in addition to TFCC tear;
4.Prior splint use or injection in the last 3 months to the affected wrist
5.Pregnancy due to risks associated with the corticosteroid injections;
6.Known allergies or adverse reactions to hydrocortisone and local anaesthetic (HCLA) injections;
7.Medical dependency that may interfere with ability to complete assessments or compliance;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in Patient Rated Wrist and Hand Evaluation (PRWHE) Score[Baseline, 6 weeks and 12 weeks after intervention commencement. ]